Clinical trial

Effects of Risperdal Consta on Ability to Benefit From Social Skills Training in…

NCT00148083 · University of Illinois at Chicago, Other · Completed

Key facts

NCT number NCT00148083
Title Effects of Risperdal Consta on Ability to Benefit From Social Skills Training in Schizophrenia
Official title Efficacy of Risperidone Consta for Improving Ability to Benefit From Skills Training in Schizophrenia
Lead sponsor University of Illinois at Chicago, Other
Collaborators Janssen, LP Industry Weill Medical College of Cornell University
Status Completed
Phase Phase 3
Study type Interventional
Conditions Schizophrenia, Schizoaffective Disorder
Intervention type Behavioral, Drug
Interventions Risperdal Consta (drug), Social Skills Training
Enrollment 5
Start date Sep 1, 2005
Primary completion Mar 1, 2006
Completion Mar 1, 2006
First posted Sep 7, 2005
Last update posted May 15, 2019
Countries United States

At a glance

  • 1–9 Study sites
  • No Results posted
  • None Linked FDA submissions

Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.

About ClinicalTrials.gov studies

ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.

Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date:

Browse all ClinicalTrials.gov studies